Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
Public ClinicalTrials.gov record NCT00005959. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II Trial of Rituximab in Combination With CHOP Chemotherapy in Patients With Previously Untreated Intermediate or High Grade Non-Hodgkin's Lymphoma
Study identification
- NCT ID
- NCT00005959
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Amgen
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- cyclophosphamide Drug
- doxorubicin hydrochloride Drug
- filgrastim Biological
- prednisone Drug
- rituximab Biological
- vincristine sulfate Drug
Drug · Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 1999
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Dec 3, 2013
Started 1999
United States locations
- U.S. sites
- 27
- U.S. states
- 20
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Montgomery Cancer Center | Montgomery | Alabama | 36106 | — |
| University of Arkansas for Medical Sciences | Little Rock | Arkansas | 72205 | — |
| Providence Saint Joseph Medical Center - Burbank | Burbank | California | 91505 | — |
| Cancer and Blood Institute of the Desert | Rancho Mirage | California | 92270 | — |
| Southeast Florida Hematology-Oncology Group | Fort Lauderdale | Florida | 33308 | — |
| Oncology-Hematology Group of South Florida | Miami | Florida | 33176 | — |
| Mount Sinai Comprehensive Cancer Center | Miami Beach | Florida | 33140 | — |
| Hematology-Oncology Associates, PA | Pensacola | Florida | 32501 | — |
| Hutchinson Clinic, P.A. | Hutchinson | Kansas | 67502 | — |
| Hematology/Oncology Care Inc. | Crestview Hills | Kentucky | 41017 | — |
| Maine Center for Cancer Medicine and Blood Disorders | Scarborough | Maine | 04074 | — |
| Associates in Oncology and Hematology | Rockville | Maryland | 20850 | — |
| North Shore Cancer Center | Peabody | Massachusetts | 01960 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| Lakeland Medical Center - St. Joseph | Saint Joseph | Michigan | 49085 | — |
| Bond Clinic | Rolla | Missouri | 65401 | — |
| Midwest Hematology Oncology Consultants, Ltd. | St Louis | Missouri | 63136 | — |
| Hematology Oncology Associates | Morristown | New Jersey | 07962 | — |
| New Mexico Oncology-Hematology | Albuquerque | New Mexico | 87109 | — |
| HemOnCare, P.C. | Brooklyn | New York | 11235 | — |
| Our Lady of Mercy Medical Center | The Bronx | New York | 10466 | — |
| N.W. Carolina Oncology & Hematology, P.A. | Hickory | North Carolina | 28603 | — |
| Oncology/Hematology Care, Inc. | Cincinnati | Ohio | 45219 | — |
| University of Tennessee, Memphis | Memphis | Tennessee | 38163 | — |
| Intermountain Hematology/Oncology Associates, Inc. | Salt Lake City | Utah | 84124 | — |
| Vermont Center for Cancer Medicine, Inc. | Colchester | Vermont | 05446 | — |
| Hematology & Oncology Associates of Virginia | Richmond | Virginia | 23226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00005959, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 3, 2013 · Synced May 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00005959 live on ClinicalTrials.gov.